Patents by Inventor Shinde Pramodb

Shinde Pramodb has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10576060
    Abstract: The present invention relates to an FK506 derivative which has reduced immunosuppressive activity but maintains nerve regeneration activity, a preparing method thereof, and a pharmaceutical composition comprising the same for preventing or treating nervous system diseases. A composition comprising 9-deoxo-prolyl-FK506, 31-O-demethyl-FK506, or 9-deoxo-31-O-demethyl-FK506 can promote nerve regeneration and has reduced immunosuppressive activity, thereby reducing side effects in the treatment of nervous system diseases.
    Type: Grant
    Filed: January 8, 2019
    Date of Patent: March 3, 2020
    Assignee: INTRON BIOTECHNOLOGY CO., LTD
    Inventors: Yeo Joon Yoon, Ho Jeong Kwon, Yeon Hee Ban, Shinde Pramodb
  • Publication number: 20190134001
    Abstract: The present invention relates to an FK506 derivative which has reduced immunosuppressive activity but maintains nerve regeneration activity, a preparing method thereof, and a pharmaceutical composition comprising the same for preventing or treating nervous system diseases. A composition comprising 9-deoxo-prolyl-FK506, 31-O-demethyl-FK506, or 9-deoxo-31-O-demethyl-FK506 can promote nerve regeneration and has reduced immunosuppressive activity, thereby reducing side effects in the treatment of nervous system diseases.
    Type: Application
    Filed: January 8, 2019
    Publication date: May 9, 2019
    Inventors: Yeo Joon Yoon, Ho Jeong Kwon, Yeon Hee Ban, Shinde Pramodb
  • Patent number: 10226446
    Abstract: The present invention relates to an FK506 derivative which has reduced immunosuppressive activity but maintains nerve regeneration activity, a preparing method thereof, and a pharmaceutical composition comprising the same for preventing or treating nervous system diseases. A composition comprising 9-deoxo-prolyl-FK506, 31-O-demethyl-FK506, or 9-deoxo-31-O-demethyl-FK506 can promote nerve regeneration and has reduced immunosuppressive activity, thereby reducing side effects in the treatment of nervous system diseases.
    Type: Grant
    Filed: July 31, 2015
    Date of Patent: March 12, 2019
    Assignee: INTRON BIOTECHNOLOGY CO., LTD
    Inventors: Yeo Joon Yoon, Ho Jeong Kwon, Yeon Hee Ban, Shinde Pramodb
  • Publication number: 20170216254
    Abstract: The present invention relates to an FK506 derivative which has reduced immunosuppressive activity but maintains nerve regeneration activity, a preparing method thereof, and a pharmaceutical composition comprising the same for preventing or treating nervous system diseases. A composition comprising 9-deoxo-prolyl-FK506, 31-O-demethyl-FK506, or 9-deoxo-31-O-demethyl-FK506 can promote nerve regeneration and has reduced immunosuppressive activity, thereby reducing side effects in the treatment of nervous system diseases.
    Type: Application
    Filed: July 31, 2015
    Publication date: August 3, 2017
    Inventors: Yeo Joon Yoon, Ho Jeong Kwon, Yeon Hee Ban, Shinde Pramodb